Literature DB >> 21947740

IL-23 in infections, inflammation, autoimmunity and cancer: possible role in HIV-1 and AIDS.

Govardhana Rao Yannam1, Tanuja Gutti, Larisa Y Poluektova.   

Abstract

The growing family of interleukin (IL)-12-like cytokines produced by activated macrophages and dendritic cells became the important players in the control of infections, development of inflammation, autoimmunity and cancer. However, the role of one of them-heterodimer IL-23, which consists of IL12p40 and the unique p19 subunit in HIV-1 infection pathogenesis and progression to AIDS, represent special interest. We overviewed findings of IL-23 involvement in control of peripheral bacterial pathogens and opportunistic infection, central nervous system (CNS) viral infections and autoimmune disorders, and tumorogenesis, which potentially could be applicable to HIV-1 and AIDS.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21947740      PMCID: PMC3288567          DOI: 10.1007/s11481-011-9315-2

Source DB:  PubMed          Journal:  J Neuroimmune Pharmacol        ISSN: 1557-1890            Impact factor:   4.147


  197 in total

Review 1.  The IL-23/Th(17) axis: therapeutic targets for autoimmune inflammation.

Authors:  Kristine Kikly; Ling Liu; Songqing Na; Jonathon D Sedgwick
Journal:  Curr Opin Immunol       Date:  2006-09-28       Impact factor: 7.486

2.  A genome-wide association study identifies IL23R as an inflammatory bowel disease gene.

Authors:  Richard H Duerr; Kent D Taylor; Steven R Brant; John D Rioux; Mark S Silverberg; Mark J Daly; A Hillary Steinhart; Clara Abraham; Miguel Regueiro; Anne Griffiths; Themistocles Dassopoulos; Alain Bitton; Huiying Yang; Stephan Targan; Lisa Wu Datta; Emily O Kistner; L Philip Schumm; Annette T Lee; Peter K Gregersen; M Michael Barmada; Jerome I Rotter; Dan L Nicolae; Judy H Cho
Journal:  Science       Date:  2006-10-26       Impact factor: 47.728

3.  TLR4 mediates vaccine-induced protective cellular immunity to Bordetella pertussis: role of IL-17-producing T cells.

Authors:  Sarah C Higgins; Andrew G Jarnicki; Ed C Lavelle; Kingston H G Mills
Journal:  J Immunol       Date:  2006-12-01       Impact factor: 5.422

4.  Mucosal but not peripheral FOXP3+ regulatory T cells are highly increased in untreated HIV infection and normalize after suppressive HAART.

Authors:  Hans-Jörg Epple; Christoph Loddenkemper; Desirée Kunkel; Hanno Tröger; Jochen Maul; Verena Moos; Erika Berg; Reiner Ullrich; Jörg-Dieter Schulzke; Harald Stein; Rainer Duchmann; Martin Zeitz; Thomas Schneider
Journal:  Blood       Date:  2006-05-25       Impact factor: 22.113

5.  IL-23 is critical in the induction but not in the effector phase of experimental autoimmune encephalomyelitis.

Authors:  Paresh Thakker; Michael W Leach; Wen Kuang; Stephen E Benoit; John P Leonard; Suzana Marusic
Journal:  J Immunol       Date:  2007-02-15       Impact factor: 5.422

6.  Interleukin-23 restores immunity to Mycobacterium tuberculosis infection in IL-12p40-deficient mice and is not required for the development of IL-17-secreting T cell responses.

Authors:  Teresa M Wozniak; Anthony A Ryan; Warwick J Britton
Journal:  J Immunol       Date:  2006-12-15       Impact factor: 5.422

7.  HIV-1-driven regulatory T-cell accumulation in lymphoid tissues is associated with disease progression in HIV/AIDS.

Authors:  Jakob Nilsson; Adriano Boasso; Paula Andrea Velilla; Rui Zhang; Monica Vaccari; Genoveffa Franchini; Gene M Shearer; Jan Andersson; Claire Chougnet
Journal:  Blood       Date:  2006-08-10       Impact factor: 22.113

8.  Peroxisome proliferator-activated receptor-gamma agonists suppress the production of IL-12 family cytokines by activated glia.

Authors:  Jihong Xu; Paul D Drew
Journal:  J Immunol       Date:  2007-02-01       Impact factor: 5.422

9.  Interleukin-23 drives innate and T cell-mediated intestinal inflammation.

Authors:  Sophie Hue; Philip Ahern; Sofia Buonocore; Marika C Kullberg; Daniel J Cua; Brent S McKenzie; Fiona Powrie; Kevin J Maloy
Journal:  J Exp Med       Date:  2006-10-09       Impact factor: 14.307

10.  Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides.

Authors:  Spencer C Liang; Xiang-Yang Tan; Deborah P Luxenberg; Riyez Karim; Kyriaki Dunussi-Joannopoulos; Mary Collins; Lynette A Fouser
Journal:  J Exp Med       Date:  2006-09-18       Impact factor: 14.307

View more
  16 in total

1.  Epidemiology: The effects of AIDS on the prevalence of rheumatic diseases.

Authors:  Chak-Sing Lau; Philip Li
Journal:  Nat Rev Rheumatol       Date:  2016-11-24       Impact factor: 20.543

2.  Inflammatory mediators of systemic inflammation in neonatal sepsis.

Authors:  V Sugitharini; A Prema; E Berla Thangam
Journal:  Inflamm Res       Date:  2013-09-08       Impact factor: 4.575

3.  Blood-based inflammation biomarkers of neurocognitive impairment in people living with HIV.

Authors:  Naomi Swanta; Subhash Aryal; Vicki Nejtek; Sangeeta Shenoy; Anuja Ghorpade; Kathleen Borgmann
Journal:  J Neurovirol       Date:  2020-03-19       Impact factor: 2.643

4.  Phosphorylated STAT3 and PD-1 regulate IL-17 production and IL-23 receptor expression in Mycobacterium tuberculosis infection.

Authors:  Anuradha Bandaru; Kamakshi P Devalraju; Padmaja Paidipally; Rohan Dhiman; Sambasivan Venkatasubramanian; Peter F Barnes; Ramakrishna Vankayalapati; Vijayalakshmi Valluri
Journal:  Eur J Immunol       Date:  2014-04-23       Impact factor: 5.532

Review 5.  Th17 cells in autoimmune and infectious diseases.

Authors:  José Francisco Zambrano-Zaragoza; Enrique Jhonatan Romo-Martínez; Ma de Jesús Durán-Avelar; Noemí García-Magallanes; Norberto Vibanco-Pérez
Journal:  Int J Inflam       Date:  2014-08-03

6.  Promoting effects of IL‑23 on myocardial ischemia and reperfusion are associated with increased expression of IL‑17A and upregulation of the JAK2‑STAT3 signaling pathway.

Authors:  Yanxi Liao; Xiaorong Hu; Xin Guo; Bofang Zhang; Weipan Xu; Hong Jiang
Journal:  Mol Med Rep       Date:  2017-10-12       Impact factor: 2.952

7.  The risk of respiratory tract infections in patients with psoriasis treated with interleukin 23 pathway-inhibiting biologics: A meta-estimate of pivotal trials relevant to decision making during the COVID-19 pandemic.

Authors:  Maha N Syed; Daniel B Shin; Marilyn T Wan; Kevin L Winthrop; Joel M Gelfand
Journal:  J Am Acad Dermatol       Date:  2020-07-02       Impact factor: 11.527

8.  In vivo effect of statins on the expression of the HIV co-receptors CCR5 and CXCR4.

Authors:  Edwin A Higuita; Fabián A Jaimes; Maria T Rugeles; Carlos J Montoya
Journal:  AIDS Res Ther       Date:  2013-05-01       Impact factor: 2.250

9.  Stromal fibroblasts support dendritic cells to maintain IL-23/Th17 responses after exposure to ionizing radiation.

Authors:  Anna Malecka; Qunwei Wang; Sabaria Shah; Ruhcha V Sutavani; Ian Spendlove; Judith M Ramage; Julie Greensmith; Hester A Franks; Michael J Gough; Anja Saalbach; Poulam M Patel; Andrew M Jackson
Journal:  J Leukoc Biol       Date:  2016-04-05       Impact factor: 4.962

10.  The Role of Interleukin-23 in the Early Development of Emphysema in HIV1(+) Smokers.

Authors:  Igor Z Barjaktarevic; Ronald G Crystal; Robert J Kaner
Journal:  J Immunol Res       Date:  2016-06-29       Impact factor: 4.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.